
Sign up to save your podcasts
Or
Cell therapies are at the cutting edge of personalized medicine but as demand for these therapies grows, how will the industry scale manufacturing to meet patient needs?
Fabian Gerlinghaus is co-founder and CEO of Cellares. He and his team have developed the Cell Shuttle, an advanced cell manufacturing technology that is already demonstrating the potential to 10x cell yields while halving costs for pharmaceuticals companies and innovators. Is this the future for smart cell manufacturing?
0:52 A starting point in aeronautical engineering
2:43 First steps into biotech
5:25 Co-founding Cellares
6:30 The problem that Cellares addresses
11:02 Best practice bio manufacturing
17:14 Differentiation in automation
18:15 What does success look like for Cellares
19:38 Smart factories
21:58 Inside the Cellares smart factory
26:34 Manufacturing CAR-T and stem cell therapies
27:54 Mass production vs personalized medicine
31:39 Global ambitions and regional regulators
35:07 Positioning Cellares in the market
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
3.3
33 ratings
Cell therapies are at the cutting edge of personalized medicine but as demand for these therapies grows, how will the industry scale manufacturing to meet patient needs?
Fabian Gerlinghaus is co-founder and CEO of Cellares. He and his team have developed the Cell Shuttle, an advanced cell manufacturing technology that is already demonstrating the potential to 10x cell yields while halving costs for pharmaceuticals companies and innovators. Is this the future for smart cell manufacturing?
0:52 A starting point in aeronautical engineering
2:43 First steps into biotech
5:25 Co-founding Cellares
6:30 The problem that Cellares addresses
11:02 Best practice bio manufacturing
17:14 Differentiation in automation
18:15 What does success look like for Cellares
19:38 Smart factories
21:58 Inside the Cellares smart factory
26:34 Manufacturing CAR-T and stem cell therapies
27:54 Mass production vs personalized medicine
31:39 Global ambitions and regional regulators
35:07 Positioning Cellares in the market
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
3,443 Listeners
26,420 Listeners
39 Listeners
111,441 Listeners
122 Listeners
317 Listeners
59 Listeners
87 Listeners
29 Listeners
147 Listeners
15,216 Listeners
10 Listeners
412 Listeners
47 Listeners
1,071 Listeners